FDA.reportPublic FDA data

Afamin IVD, kit, enzyme immunoassay (EIA)

Definition
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of afamin, also known as alpha-albumin (previously known as alpha-1-T glycoprotein), in a clinical specimen, using an enzyme immunoassay (EIA) method. Afamin has been associated with metabolic syndrome, insulin resistance and ovarian cancer.
GUDID devices
12
Last updated
2024-06-18 07:42:11

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
08714729765240WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169002015-09-24
08714729765257WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169102015-09-24
08714729765264WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169202015-09-24
08714729765271WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169302015-09-24
08714729765288WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169402015-09-24
08714729765295WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005169502015-09-24
08714729778035WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167002015-09-24
08714729778042WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167102015-09-24
08714729778059WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167202015-09-24
08714729778066WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167302015-09-24
08714729778073WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167402015-09-24
08714729778080WallFlex™ EsophagealBOSTON SCIENTIFIC CORPORATIONM005167502015-09-24